APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Custom Adeno-Associated Virus (AAV) Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Custom Adeno-Associated Virus (AAV) Services Market Outlook and Growth Opportunities 2026

Report ID 17410794043 May 2026192 pages

Choose your research edition.

Industry ResearchCustom Adeno-Associated Virus (AAV) Services Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Adeno-Associated Virus (AAV) Services Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Custom Adeno-Associated Virus (AAV) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Adeno-Associated Virus (AAV) Services Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Adeno-Associated Virus (AAV) Services Market Analysis and Forecast 2026-2032225 pages · $4,950 USD

Market perspective

The global Custom Adeno-Associated Virus (AAV) Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Custom Adeno-Associated Virus (AAV) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Custom Adeno-Associated Virus (AAV) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Adeno-Associated Virus (AAV) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Custom Adeno-Associated Virus (AAV) Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Custom Adeno-Associated Virus (AAV) Services market include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics（MolMed） and Gene Universal, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Custom Adeno-Associated Virus (AAV) Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Custom Adeno-Associated Virus (AAV) Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Custom Adeno-Associated Virus (AAV) Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Adeno-Associated Virus (AAV) Services market.

Custom Adeno-Associated Virus (AAV) Services Segment by Company

Thermo Fisher Scientific

Lonza

Catalent

Charles River

Merck

SK pharmteco

Oxford Biomedica

AGC Biologics（MolMed）

Gene Universal

Polyplus (Sartorius)

CCRM

FUJIFILM Diosynth Biotechnologies

Biovian

Miltenyi Bioindustry

Aldevron

Takara Bio

Yposkesi

Genezen

Exthera

GenScript ProBio

EurekaBio

Obio Technology

GeneSail Biotech

VectorBuilder

WuXi ATU

Ubrigene

Porton Biologics

Pharmaron

PackGene Biotechnology

Custom Adeno-Associated Virus (AAV) Services Segment by Type

Adherent Culture

Suspension Culture

Custom Adeno-Associated Virus (AAV) Services Segment by Application

Vaccine Development

Gene Therapy

Academic Scientific Research Institution

Others

Custom Adeno-Associated Virus (AAV) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Custom Adeno-Associated Virus (AAV) Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Custom Adeno-Associated Virus (AAV) Services key companies, revenue, market share, and recent developments.

3. To split the Custom Adeno-Associated Virus (AAV) Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Custom Adeno-Associated Virus (AAV) Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Custom Adeno-Associated Virus (AAV) Services significant trends, drivers, influence factors in global and regions.

6. To analyze Custom Adeno-Associated Virus (AAV) Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Adeno-Associated Virus (AAV) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Adeno-Associated Virus (AAV) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Adeno-Associated Virus (AAV) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Adeno-Associated Virus (AAV) Services industry.

Chapter 3: Detailed analysis of Custom Adeno-Associated Virus (AAV) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Custom Adeno-Associated Virus (AAV) Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Custom Adeno-Associated Virus (AAV) Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Custom Adeno-Associated Virus (AAV) Services Industry Trends Table 2. Custom Adeno-Associated Virus (AAV) Services Industry Drivers Table 3. Custom Adeno-Associated Virus (AAV) Services Industry Opportunities and Challenges Table 4. Custom Adeno-Associated Virus (AAV) Services Industry Restraints Table 5. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Custom Adeno-Associated Virus (AAV) Services Revenue Share by Company (2021-2026) Table 7. Global Custom Adeno-Associated Virus (AAV) Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Custom Adeno-Associated Virus (AAV) Services Key Company Manufacturing Base & Headquarters Table 9. Global Custom Adeno-Associated Virus (AAV) Services Company, Product Type & Application Table 10. Global Custom Adeno-Associated Virus (AAV) Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Custom Adeno-Associated Virus (AAV) Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Adherent Culture Table 15. Significant Companies of Suspension Culture Table 16. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type (2021-2026) Table 20. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Vaccine Development Table 22. Significant Companies of Gene Therapy Table 23. Significant Companies of Academic Scientific Research Institution Table 24. Significant Companies of Others Table 25. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application (2021-2026) Table 29. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application (2027-2032) Table 30. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Region (2021-2026) Table 33. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Region (2027-2032) Table 35. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Market Share by Country (2021-2026) Table 38. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Market Share by Country (2027-2032) Table 40. Thermo Fisher Scientific Company Information Table 41. Thermo Fisher Scientific Business Overview Table 42. Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 44. Thermo Fisher Scientific Recent Development Table 45. Lonza Company Information Table 46. Lonza Business Overview Table 47. Lonza Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Lonza Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 49. Lonza Recent Development Table 50. Catalent Company Information Table 51. Catalent Business Overview Table 52. Catalent Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Catalent Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 54. Catalent Recent Development Table 55. Charles River Company Information Table 56. Charles River Business Overview Table 57. Charles River Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Charles River Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 59. Charles River Recent Development Table 60. Merck Company Information Table 61. Merck Business Overview Table 62. Merck Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Merck Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 64. Merck Recent Development Table 65. SK pharmteco Company Information Table 66. SK pharmteco Business Overview Table 67. SK pharmteco Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. SK pharmteco Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 69. SK pharmteco Recent Development Table 70. Oxford Biomedica Company Information Table 71. Oxford Biomedica Business Overview Table 72. Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 74. Oxford Biomedica Recent Development Table 75. AGC Biologics（MolMed） Company Information Table 76. AGC Biologics（MolMed） Business Overview Table 77. AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 79. AGC Biologics（MolMed） Recent Development Table 80. Gene Universal Company Information Table 81. Gene Universal Business Overview Table 82. Gene Universal Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Gene Universal Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 84. Gene Universal Recent Development Table 85. Polyplus (Sartorius) Company Information Table 86. Polyplus (Sartorius) Business Overview Table 87. Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 89. Polyplus (Sartorius) Recent Development Table 90. CCRM Company Information Table 91. CCRM Business Overview Table 92. CCRM Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. CCRM Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 94. CCRM Recent Development Table 95. FUJIFILM Diosynth Biotechnologies Company Information Table 96. FUJIFILM Diosynth Biotechnologies Business Overview Table 97. FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 99. FUJIFILM Diosynth Biotechnologies Recent Development Table 100. Biovian Company Information Table 101. Biovian Business Overview Table 102. Biovian Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Biovian Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 104. Biovian Recent Development Table 105. Miltenyi Bioindustry Company Information Table 106. Miltenyi Bioindustry Business Overview Table 107. Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 109. Miltenyi Bioindustry Recent Development Table 110. Aldevron Company Information Table 111. Aldevron Business Overview Table 112. Aldevron Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Aldevron Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 114. Aldevron Recent Development Table 115. Takara Bio Company Information Table 116. Takara Bio Business Overview Table 117. Takara Bio Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Takara Bio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 119. Takara Bio Recent Development Table 120. Yposkesi Company Information Table 121. Yposkesi Business Overview Table 122. Yposkesi Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Yposkesi Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 124. Yposkesi Recent Development Table 125. Genezen Company Information Table 126. Genezen Business Overview Table 127. Genezen Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Genezen Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 129. Genezen Recent Development Table 130. Exthera Company Information Table 131. Exthera Business Overview Table 132. Exthera Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Exthera Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 134. Exthera Recent Development Table 135. GenScript ProBio Company Information Table 136. GenScript ProBio Business Overview Table 137. GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 139. GenScript ProBio Recent Development Table 140. EurekaBio Company Information Table 141. EurekaBio Business Overview Table 142. EurekaBio Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. EurekaBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 144. EurekaBio Recent Development Table 145. Obio Technology Company Information Table 146. Obio Technology Business Overview Table 147. Obio Technology Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Obio Technology Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 149. Obio Technology Recent Development Table 150. GeneSail Biotech Company Information Table 151. GeneSail Biotech Business Overview Table 152. GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 154. GeneSail Biotech Recent Development Table 155. VectorBuilder Company Information Table 156. VectorBuilder Business Overview Table 157. VectorBuilder Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 158. VectorBuilder Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 159. VectorBuilder Recent Development Table 160. WuXi ATU Company Information Table 161. WuXi ATU Business Overview Table 162. WuXi ATU Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 163. WuXi ATU Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 164. WuXi ATU Recent Development Table 165. Ubrigene Company Information Table 166. Ubrigene Business Overview Table 167. Ubrigene Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 168. Ubrigene Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 169. Ubrigene Recent Development Table 170. Porton Biologics Company Information Table 171. Porton Biologics Business Overview Table 172. Porton Biologics Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 173. Porton Biologics Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 174. Porton Biologics Recent Development Table 175. Pharmaron Company Information Table 176. Pharmaron Business Overview Table 177. Pharmaron Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 178. Pharmaron Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 179. Pharmaron Recent Development Table 180. PackGene Biotechnology Company Information Table 181. PackGene Biotechnology Business Overview Table 182. PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 183. PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 184. PackGene Biotechnology Recent Development Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Custom Adeno-Associated Virus (AAV) Services Product Image Figure 2. Global Custom Adeno-Associated Virus (AAV) Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Adeno-Associated Virus (AAV) Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Custom Adeno-Associated Virus (AAV) Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Adherent Culture Image Figure 8. Suspension Culture Image Figure 9. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type (2021-2032) Figure 12. Vaccine Development Image Figure 13. Gene Therapy Image Figure 14. Academic Scientific Research Institution Image Figure 15. Others Image Figure 16. Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application (2021-2032) Figure 19. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Custom Adeno-Associated Virus (AAV) Services Sales Value (2021-2032) & (US$ Million) Figure 22. North America Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Custom Adeno-Associated Virus (AAV) Services Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Custom Adeno-Associated Virus (AAV) Services Sales Value (2021-2032) & (US$ Million) Figure 28. South America Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Adherent Culture
  • Suspension Culture
Applications
  • Vaccine Development
  • Gene Therapy
  • Academic Scientific Research Institution
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Lonza
  • Catalent
  • Charles River
  • Merck
  • SK pharmteco
  • Oxford Biomedica
  • AGC Biologics（MolMed）
  • Gene Universal
  • Polyplus (Sartorius)
  • CCRM
  • FUJIFILM Diosynth Biotechnologies
  • Biovian
  • Miltenyi Bioindustry
  • Aldevron
  • Takara Bio
  • Yposkesi
  • Genezen
  • Exthera
  • GenScript ProBio
  • EurekaBio
  • Obio Technology
  • GeneSail Biotech
  • VectorBuilder
  • WuXi ATU
  • Ubrigene
  • Porton Biologics
  • Pharmaron
  • PackGene Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Custom Adeno-Associated Virus (AAV) Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Custom Adeno-Associated Virus (AAV) Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Custom Adeno-Associated Virus (AAV) Services Market Dynamics
  1. 2.1 Custom Adeno-Associated Virus (AAV) Services Industry Trends
  2. 2.2 Custom Adeno-Associated Virus (AAV) Services Industry Drivers
  3. 2.3 Custom Adeno-Associated Virus (AAV) Services Industry Opportunities and Challenges
  4. 2.4 Custom Adeno-Associated Virus (AAV) Services Industry Restraints
3 Custom Adeno-Associated Virus (AAV) Services Market by Company
  1. 3.1 Global Custom Adeno-Associated Virus (AAV) Services Company Revenue Ranking in 2025
  2. 3.2 Global Custom Adeno-Associated Virus (AAV) Services Revenue by Company (2021-2026)
  3. 3.3 Global Custom Adeno-Associated Virus (AAV) Services Company Ranking (2024-2026)
  4. 3.4 Global Custom Adeno-Associated Virus (AAV) Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Custom Adeno-Associated Virus (AAV) Services Company Product Type and Application
  6. 3.6 Global Custom Adeno-Associated Virus (AAV) Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Custom Adeno-Associated Virus (AAV) Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Custom Adeno-Associated Virus (AAV) Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Custom Adeno-Associated Virus (AAV) Services Market by Type
  1. 4.1 Custom Adeno-Associated Virus (AAV) Services Type Introduction
  2. 4.1.1 Adherent Culture
  3. 4.1.2 Suspension Culture
  4. 4.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type
  5. 4.2.1 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type (2021-2032)
5 Custom Adeno-Associated Virus (AAV) Services Market by Application
  1. 5.1 Custom Adeno-Associated Virus (AAV) Services Application Introduction
  2. 5.1.1 Vaccine Development
  3. 5.1.2 Gene Therapy
  4. 5.1.3 Academic Scientific Research Institution
  5. 5.1.4 Others
  6. 5.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application
  7. 5.2.1 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application (2021-2032)
6 Custom Adeno-Associated Virus (AAV) Services Regional Value Analysis
  1. 6.1 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Custom Adeno-Associated Virus (AAV) Services Sales Value (2021-2032)
  7. 6.3.2 North America Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Custom Adeno-Associated Virus (AAV) Services Sales Value (2021-2032)
  10. 6.4.2 Europe Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Custom Adeno-Associated Virus (AAV) Services Sales Value (2021-2032)
  16. 6.6.2 South America Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Country, 2025 VS 2032
7 Custom Adeno-Associated Virus (AAV) Services Country-level Value Analysis
  1. 7.1 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Custom Adeno-Associated Virus (AAV) Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Custom Adeno-Associated Virus (AAV) Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Custom Adeno-Associated Virus (AAV) Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Lonza
  8. 8.2.1 Lonza Company Information
  9. 8.2.2 Lonza Business Overview
  10. 8.2.3 Lonza Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lonza Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  12. 8.2.5 Lonza Recent Developments
  13. 8.3 Catalent
  14. 8.3.1 Catalent Company Information
  15. 8.3.2 Catalent Business Overview
  16. 8.3.3 Catalent Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Catalent Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  18. 8.3.5 Catalent Recent Developments
  19. 8.4 Charles River
  20. 8.4.1 Charles River Company Information
  21. 8.4.2 Charles River Business Overview
  22. 8.4.3 Charles River Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Charles River Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  24. 8.4.5 Charles River Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 SK pharmteco
  32. 8.6.1 SK pharmteco Company Information
  33. 8.6.2 SK pharmteco Business Overview
  34. 8.6.3 SK pharmteco Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SK pharmteco Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  36. 8.6.5 SK pharmteco Recent Developments
  37. 8.7 Oxford Biomedica
  38. 8.7.1 Oxford Biomedica Company Information
  39. 8.7.2 Oxford Biomedica Business Overview
  40. 8.7.3 Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  42. 8.7.5 Oxford Biomedica Recent Developments
  43. 8.8 AGC Biologics（MolMed）
  44. 8.8.1 AGC Biologics（MolMed） Company Information
  45. 8.8.2 AGC Biologics（MolMed） Business Overview
  46. 8.8.3 AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  48. 8.8.5 AGC Biologics（MolMed） Recent Developments
  49. 8.9 Gene Universal
  50. 8.9.1 Gene Universal Company Information
  51. 8.9.2 Gene Universal Business Overview
  52. 8.9.3 Gene Universal Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Gene Universal Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  54. 8.9.5 Gene Universal Recent Developments
  55. 8.10 Polyplus (Sartorius)
  56. 8.10.1 Polyplus (Sartorius) Company Information
  57. 8.10.2 Polyplus (Sartorius) Business Overview
  58. 8.10.3 Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  60. 8.10.5 Polyplus (Sartorius) Recent Developments
  61. 8.11 CCRM
  62. 8.11.1 CCRM Company Information
  63. 8.11.2 CCRM Business Overview
  64. 8.11.3 CCRM Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CCRM Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  66. 8.11.5 CCRM Recent Developments
  67. 8.12 FUJIFILM Diosynth Biotechnologies
  68. 8.12.1 FUJIFILM Diosynth Biotechnologies Company Information
  69. 8.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
  70. 8.12.3 FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  72. 8.12.5 FUJIFILM Diosynth Biotechnologies Recent Developments
  73. 8.13 Biovian
  74. 8.13.1 Biovian Company Information
  75. 8.13.2 Biovian Business Overview
  76. 8.13.3 Biovian Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Biovian Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  78. 8.13.5 Biovian Recent Developments
  79. 8.14 Miltenyi Bioindustry
  80. 8.14.1 Miltenyi Bioindustry Company Information
  81. 8.14.2 Miltenyi Bioindustry Business Overview
  82. 8.14.3 Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  84. 8.14.5 Miltenyi Bioindustry Recent Developments
  85. 8.15 Aldevron
  86. 8.15.1 Aldevron Company Information
  87. 8.15.2 Aldevron Business Overview
  88. 8.15.3 Aldevron Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Aldevron Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  90. 8.15.5 Aldevron Recent Developments
  91. 8.16 Takara Bio
  92. 8.16.1 Takara Bio Company Information
  93. 8.16.2 Takara Bio Business Overview
  94. 8.16.3 Takara Bio Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Takara Bio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  96. 8.16.5 Takara Bio Recent Developments
  97. 8.17 Yposkesi
  98. 8.17.1 Yposkesi Company Information
  99. 8.17.2 Yposkesi Business Overview
  100. 8.17.3 Yposkesi Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Yposkesi Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  102. 8.17.5 Yposkesi Recent Developments
  103. 8.18 Genezen
  104. 8.18.1 Genezen Company Information
  105. 8.18.2 Genezen Business Overview
  106. 8.18.3 Genezen Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Genezen Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  108. 8.18.5 Genezen Recent Developments
  109. 8.19 Exthera
  110. 8.19.1 Exthera Company Information
  111. 8.19.2 Exthera Business Overview
  112. 8.19.3 Exthera Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Exthera Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  114. 8.19.5 Exthera Recent Developments
  115. 8.20 GenScript ProBio
  116. 8.20.1 GenScript ProBio Company Information
  117. 8.20.2 GenScript ProBio Business Overview
  118. 8.20.3 GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  120. 8.20.5 GenScript ProBio Recent Developments
  121. 8.21 EurekaBio
  122. 8.21.1 EurekaBio Company Information
  123. 8.21.2 EurekaBio Business Overview
  124. 8.21.3 EurekaBio Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 EurekaBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  126. 8.21.5 EurekaBio Recent Developments
  127. 8.22 Obio Technology
  128. 8.22.1 Obio Technology Company Information
  129. 8.22.2 Obio Technology Business Overview
  130. 8.22.3 Obio Technology Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Obio Technology Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  132. 8.22.5 Obio Technology Recent Developments
  133. 8.23 GeneSail Biotech
  134. 8.23.1 GeneSail Biotech Company Information
  135. 8.23.2 GeneSail Biotech Business Overview
  136. 8.23.3 GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  137. 8.23.4 GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  138. 8.23.5 GeneSail Biotech Recent Developments
  139. 8.24 VectorBuilder
  140. 8.24.1 VectorBuilder Company Information
  141. 8.24.2 VectorBuilder Business Overview
  142. 8.24.3 VectorBuilder Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  143. 8.24.4 VectorBuilder Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  144. 8.24.5 VectorBuilder Recent Developments
  145. 8.25 WuXi ATU
  146. 8.25.1 WuXi ATU Company Information
  147. 8.25.2 WuXi ATU Business Overview
  148. 8.25.3 WuXi ATU Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  149. 8.25.4 WuXi ATU Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  150. 8.25.5 WuXi ATU Recent Developments
  151. 8.26 Ubrigene
  152. 8.26.1 Ubrigene Company Information
  153. 8.26.2 Ubrigene Business Overview
  154. 8.26.3 Ubrigene Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Ubrigene Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  156. 8.26.5 Ubrigene Recent Developments
  157. 8.27 Porton Biologics
  158. 8.27.1 Porton Biologics Company Information
  159. 8.27.2 Porton Biologics Business Overview
  160. 8.27.3 Porton Biologics Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Porton Biologics Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  162. 8.27.5 Porton Biologics Recent Developments
  163. 8.28 Pharmaron
  164. 8.28.1 Pharmaron Company Information
  165. 8.28.2 Pharmaron Business Overview
  166. 8.28.3 Pharmaron Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Pharmaron Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  168. 8.28.5 Pharmaron Recent Developments
  169. 8.29 PackGene Biotechnology
  170. 8.29.1 PackGene Biotechnology Company Information
  171. 8.29.2 PackGene Biotechnology Business Overview
  172. 8.29.3 PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Revenue and Gross Margin (2021-2026)
  173. 8.29.4 PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  174. 8.29.5 PackGene Biotechnology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst